注射型流感疫苗市場：依疫苗類型、價數、給藥途徑、年齡層、技術平台、通路、適應症、株類型和地區分類。

預計到2026年，注射型流感疫苗市場規模將達到98.1億美元，到2033年將達到163.9億美元。預計2026年至2033年，該市場將以7.6%的複合年成長率成長。

全球注射型流感疫苗市場在全球免疫領域佔有重要佔有率，涵蓋肌肉注射型流感疫苗的研發、生產和分銷。這些疫苗是預防季節性流感的主要手段，季節性流感每年影響全球數百萬人，對公共衛生和經濟造成沉重負擔。注射型流感疫苗市場包含多種疫苗配方，旨在提供多種流感病毒株的保護，例如三價和四價去活化流感疫苗、減毒活病毒疫苗和重組流感疫苗。

市場動態受多種因素影響，例如季節性需求模式、政府免疫政策、醫療基礎設施發展以及疫苗技術的進步。領先的製藥和生技公司不斷加大研發投入，以提高疫苗效力、減少副作用並改善生產流程。市場涵蓋多種分銷管道，包括醫院、診所、藥房和大型免疫中心，目標人群涵蓋從兒童到老年人的各個年齡層。在預防醫學意識不斷增強、人們認知到免疫接種計劃的經濟效益、以及已開發市場和新興市場技術進步和疫苗接種管道不斷擴大的推動下，全球流感疫苗（注射劑）市場持續發展。

市場動態

全球流感疫苗（注射劑）市場受多種關鍵因素驅動，這些因素共同推動其成長。政府對疫苗接種計畫的投入和資金的增加，尤其是在應對流感大流行和季節性流感爆發方面，是推動市場成長的主要催化劑。消費者健康意識的提高，以及老年人口的不斷成長（老年人更容易出現流感併發症），顯著推動了市場需求。疫苗研發技術的進步，包括細胞培養和重組疫苗生產方法，提高了疫苗的有效性和安全性，從而提高了患者的接受度。新興經濟體醫療基礎設施的擴建和低溫運輸物流的改善，促進了疫苗的分發和普及。

然而，市場面臨許多限制因素，包括某些人群對疫苗接種的猶豫、對副作用的擔憂以及可能延緩產品核准和上市的複雜監管流程。季節性需求波動給製造商帶來供應鏈挑戰和庫存管理難題。高昂的研發成本，尤其是通用流感疫苗的研發成本，對市場參與者而言是一筆不小的財務負擔。此外，來自其他給藥途徑（例如鼻噴霧疫苗）的競爭可能會限制注射型疫苗的市場佔有率。儘管存在這些挑戰，但開發中國家擁有大量未接種疫苗的人口）、可能提供長期保護的通用流感疫苗的研發以及數位健康技術在改善疫苗接種追蹤和患者參與度方面的應用，都蘊藏著巨大的機遇。

本次調查的主要特點

• 本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
• 此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及主要參與者採取的競爭策略。
• 本研究根據以下參數創建了全球流感疫苗（注射劑）市場主要公司的概況：公司概況、產品系列、主要亮點、財務表現和策略。
• 透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
• 這份全球注射型流感疫苗市場報告的目標對象包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等產業相關人員。
• 相關人員可以透過分析全球注射型流感疫苗市場中使用的各種策略矩陣輕鬆做出決策。

目錄

第1章：研究目標與前提條件

• 分析目的
• 先決條件
• 簡稱

第2章 市場展望

• 報告說明
  • 市場定義和範圍
• 執行摘要

第3章：市場動態、監管與趨勢分析

• 市場動態
• 促進因素
• 抑制因子
• 機會
• 影響分析
• 主要進展
• 監管趨勢
• 產品上市及核准
• PEST分析
• 波特的分析
• 併購情景
• 產業趨勢

第4章 全球注射型流感疫苗市場：依疫苗類型分類，2021-2033年

• 失活
• 衰減

第5章 全球注射型流感疫苗市場：依價態分類，2021-2033年

• 四價
• 三價

第6章 全球注射型流感疫苗市場：依給藥途徑分類，2021-2033年

• 注射
• 鼻噴霧

第7章 全球注射型流感疫苗市場：依年齡層別分類，2021-2033年

• 兒童
• 成人

第8章 全球注射型流感疫苗市場：依技術平台分類，2021-2033年

• 蛋製品
• 基於細胞
• 重組
• 基於mRNA的

第9章 全球注射型流感疫苗市場：依通路分類，2021-2033年

• 醫院和零售藥局
• 政府和機構的供應商
• 其他（例如，非政府組織、國際組織）

第10章 全球注射型流感疫苗市場：依適應症分類，2021-2033年

• 季節性
• 大流行

第11章 全球注射型流感疫苗市場：依株型態分類，2021-2033年

• A（H1N1）
• A（H3N2）
• B（山形）
• B（維多利亞）

第12章 全球注射型流感疫苗市場：依地區分類，2021-2033年

• 北美洲
  • 美國
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲國家
• 歐洲
  • 德國
  • 英國
  • 西班牙
  • 法國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • ASEAN
  • 其他亞太國家
• 中東
  • 海灣合作理事會國家
  • 以色列
  • 其他中東國家
• 非洲
  • 南非
  • 北非
  • 中非

第13章 競爭格局

• Sanofi Pasteur
• GlaxoSmithKline
• CSL Seqirus
• AstraZeneca
• Pfizer
• Merck
• Moderna
• Novavax
• Bharat Biotech
• Sinovac Biotech
• Serum Institute of India
• Daiichi Sankyo
• Emergent BioSolutions
• BIKEN Co., Ltd.
• Abbott Laboratories

第14章 分析師建議

• 機會分析
• 分析師意見
• Coherent Opportunity Map

第15章 參考文獻與調查方法

• 參考
• 調查方法
• 關於本公司

Injection Flu Shot Market is estimated to be valued at USD 9.81 Bn in 2026 and is expected to reach USD 16.39 Bn by 2033, growing at a compound annual growth rate (CAGR) of 7.6% from 2026 to 2033.

The global injection flu shot market represents a critical segment within the global immunization landscape, encompassing the development, manufacturing, and distribution of influenza vaccines administered through intramuscular injection. These vaccines serve as the primary prophylactic measure against seasonal influenza, which affects millions of individuals worldwide annually and poses significant public health and economic burdens. The injection flu shot market includes various vaccine formulations such as trivalent and quadrivalent inactivated influenza vaccines, live attenuated influenza vaccines, and recombinant influenza vaccines, each designed to provide protection against multiple influenza virus strains.

The market dynamics are influenced by factors including seasonal demand patterns, government immunization policies, healthcare infrastructure development, and evolving vaccine technologies. Major pharmaceutical companies and biotechnology firms continuously invest in research and development to enhance vaccine efficacy, reduce adverse effects, and improve manufacturing processes. The market encompasses diverse distribution channels including hospitals, clinics, pharmacies, and mass vaccination centers, serving various demographic segments from pediatric to geriatric populations. With increasing awareness about preventive healthcare and the economic benefits of vaccination programs, the global injection flu shot market continues to evolve, driven by technological advancements and expanding accessibility across both developed and emerging markets.

Market Dynamics

The global injection flu shot market is propelled by several key drivers that collectively fuel its growth trajectory. Increasing government initiatives and funding for vaccination programs, particularly in response to pandemic preparedness and seasonal flu outbreaks, serve as primary growth catalysts. Rising healthcare awareness among consumers, coupled with growing elderly populations who are more susceptible to influenza complications, significantly drives market demand. Technological advancements in vaccine development, including cell-based and recombinant vaccine production methods, enhance vaccine efficacy and safety profiles, attracting broader patient acceptance. Expanding healthcare infrastructure in emerging economies and improved cold chain logistics facilitate better vaccine distribution and accessibility.

However, the market faces notable restraints including vaccine hesitancy among certain population segments, concerns about adverse effects, and regulatory complexities that can delay product approvals and market entry. Seasonal demand fluctuations create supply chain challenges and inventory management issues for manufacturers. High research and development costs, particularly for developing universal flu vaccines, pose financial constraints for market players. Additionally, competition from alternative vaccination routes such as nasal spray vaccines may limit market share for injection-based products. Despite these challenges, significant opportunities emerge from untapped markets in developing countries with large unvaccinated populations, development of universal flu vaccines that could provide long-term protection, and integration of digital health technologies for improved vaccination tracking and patient engagement.

Key Features of the Study

• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global injection flu shot market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Sanofi Pasteur, GlaxoSmithKline, CSL Seqirus, AstraZeneca, Pfizer, Merck, Moderna, Novavax, Bharat Biotech, Sinovac Biotech, Serum Institute of India, Daiichi Sankyo, Emergent BioSolutions, BIKEN Co., Ltd., and Abbott Laboratories.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global injection flu shot market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global injection flu shot market

Market Segmentation

• Vaccine Type Insights (Revenue, USD Bn, 2021 - 2033)
• Inactivated
• Live Attenuated
• Valency Insights (Revenue, USD Bn, 2021 - 2033)
• Quadrivalent
• Trivalent
• Route of Administration Insights (Revenue, USD Bn, 2021 - 2033)
• Injection
• Nasal Spray
• Age Group Insights (Revenue, USD Bn, 2021 - 2033)
• Pediatric
• Adult
• Technology Platform Insights (Revenue, USD Bn, 2021 - 2033)
• Egg-based
• Cell-based
• Recombinant
• mRNA-based
• Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
• Hospital and Retail Pharmacies
• Government & Institutional Suppliers
• Others (e.g., NGOs, International Organizations)
• Indication Insights (Revenue, USD Bn, 2021 - 2033)
• Seasonal
• Pandemic
• Strain Type Insights (Revenue, USD Bn, 2021 - 2033)
• A(H1N1)
• A(H3N2)
• B (Yamagata)
• B (Victoria)
• Regional Insights (Revenue, USD Bn, 2021 - 2033)
• North America
  • U.S.
  • Canada
• Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
• Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
• Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
• Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
• Sanofi Pasteur
• GlaxoSmithKline
• CSL Seqirus
• AstraZeneca
• Pfizer
• Merck
• Moderna
• Novavax
• Bharat Biotech
• Sinovac Biotech
• Serum Institute of India
• Daiichi Sankyo
• Emergent BioSolutions
• BIKEN Co., Ltd.
• Abbott Laboratories

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Injection Flu Shot Market, By Vaccine Type
  • Global Injection Flu Shot Market, By Valency
  • Global Injection Flu Shot Market, By Route of Administration
  • Global Injection Flu Shot Market, By Age Group
  • Global Injection Flu Shot Market, By Technology Platform
  • Global Injection Flu Shot Market, By Distribution Channel
  • Global Injection Flu Shot Market, By Indication
  • Global Injection Flu Shot Market, By Strain Type
  • Global Injection Flu Shot Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Injection Flu Shot Market, By Vaccine Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Inactivated
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Live Attenuated
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global Injection Flu Shot Market, By Valency, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Quadrivalent
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Trivalent
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global Injection Flu Shot Market, By Route of Administration, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Injection
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Nasal Spray
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global Injection Flu Shot Market, By Age Group, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Pediatric
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Adult
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global Injection Flu Shot Market, By Technology Platform, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Egg-based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Cell-based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Recombinant
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• mRNA-based
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global Injection Flu Shot Market, By Distribution Channel, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Hospital and Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Government & Institutional Suppliers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Others (e.g., NGOs, International Organizations)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

10. Global Injection Flu Shot Market, By Indication, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• Seasonal
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• Pandemic
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

11. Global Injection Flu Shot Market, By Strain Type, 2021 - 2033, (USD Bn)

• Introduction
  • Market Share Analysis, 2026 and 2033 (%)
  • Y-o-Y Growth Analysis, 2022 - 2033
  • Segment Trends
• A(H1N1)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• A(H3N2)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• B (Yamagata)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
• B (Victoria)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

12. Global Injection Flu Shot Market, By Region, 2021 - 2033, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Valency, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Strain Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Valency, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Strain Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Valency, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Strain Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Valency, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Strain Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Valency, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Strain Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Vaccine Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Valency, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Route of Administration, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Technology Platform, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Indication, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Strain Type, 2021 - 2033, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

13. Competitive Landscape

• Sanofi Pasteur
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GlaxoSmithKline
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• CSL Seqirus
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AstraZeneca
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Merck
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Moderna
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Novavax
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bharat Biotech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sinovac Biotech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Serum Institute of India
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Daiichi Sankyo
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Emergent BioSolutions
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• BIKEN Co., Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Abbott Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

14. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

15. References and Research Methodology

• References
• Research Methodology
• About us